Candida auris as a significant emerging human fungal pathogen

Candida auris, an Emerging Fungal Pathogen

The emerging pathogen “Candida auris” is attracting considerable international attention due to its rising reports, transmission through health professionals, high rate of treatment failure and resistance to multiple antifungal agents, particularly fluconazole. In spite of the global emergence of C. auris, epidemiological data and true prevalence of infections due to this organism are not clear...

Candida parapsilosis, an Emerging Fungal Pathogen

INTRODUCTION .......................................................................................................................................................606 PREVALENCE ............................................................................................................................................................607 RISK FACTORS ................................................

Candida parapsilosis: an emerging fungal pathogen

SUMMARY Candida parapsilosis is an emerging major human pathogen that has dramatically increased in significance and prevalence over the past 2 decades, such that C. parapsilosis is now one of the leading causes of invasive candidal disease. Individuals at the highest risk for severe infection include neonates and patients in intensive care units. C. parapsilosis infections are especially assoc...

Rapid genome sequencing for outbreak analysis of the emerging human fungal 1 pathogen Candida auris 2 3

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide. Candida bloodstream infections (BSI) cause significant mortality and elicit a major threat to intensive care unit (ICU) patients [1]. The annual global burden of Candida spp. BSIs is about 400,000 cases, with most cases reported from the developed world. Although...